CellWell record HH-435387
A selenium-containing selective estrogen receptor modulator to overcome drug resistance of chronic myeloid leukemia
Liu J; Yang C; Gu D; Guo L; Zeng Y; Guo Q; Yang Y; Meng Q; Shu J; Liu W; Yang L
Apoptosis : an international journal on programmed cell death ยท 2026
In plain language
A novel selenium compound, Se-1, suppressed adriamycin-resistant chronic myeloid leukemia cells more strongly than sensitive cells and slowed resistant tumor growth in mice, acting through apoptosis and autophagy.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-435387
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.